Workflow
Evoke Pharma(EVOK) - 2025 Q1 - Quarterly Results
Evoke PharmaEvoke Pharma(US:EVOK)2025-05-13 20:15

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update Q1 2025 Net Product Sales Increased 77% Year-over-Year to $3.1 Million Sustained Momentum Driven by Growing Prescriber Adoption and Repeat Patient Use SOLANA BEACH, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an emphasis on GIMOTI ®, today announced financial results for the first quarter ended ...